Viatris Inc (VTRS) income statement
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.28−0.17 (-0.83%)
Close on Nov 18, 2026Market cap $23.29BP/E –Yield 2.37%
Viatris Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 34.8%
- Operating margin
- -0.6%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 1.58
- Debt to equity
- –
- Debt to assets
- 38.1%
- Cash to current liabilities
- 14.0%
Valuation
- P/E ratio
- –
- Price to sales
- 1.58
- Price to book
- –
- Dividend yield
- 2.37%
See a number that looks wrong?